If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where nobuko yasutake is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Leiomyosarcoma Medicine & Life Sciences
Struma Ovarii Medicine & Life Sciences
Abdominal Pregnancy Medicine & Life Sciences
PAR-2 Receptor Medicine & Life Sciences
Hemoperitoneum Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Insulin-Like Growth Factor II Medicine & Life Sciences
RNA-Binding Proteins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2013 2018

  • 38 Citations
  • 4 h-Index
  • 6 Article
  • 1 Review article
1 Citation (Scopus)

Cancer-testis antigens are predominantly expressed in uterine leiomyosarcoma compared with non-uterine leiomyosarcoma

Iura, K., Kohashi, K., Yasutake, N., Ishii, T., Maekawa, A., Bekki, H., Otsuka, H., Yamada, Y., Yamamoto, H., Ohishi, Y., Matsumoto, Y., Iwamoto, Y. & Oda, Y., Jan 2018, In : Oncology Letters. 15, 1, p. 441-446 6 p.

Research output: Contribution to journalArticle

Testicular Neoplasms
2 Citations (Scopus)

Insulin-like growth factor II messenger RNA-binding protein-3 is an independent prognostic factor in uterine leiomyosarcoma

Yasutake, N., Ohishi, Y., Taguchi, K., Hiraki, Y., Oya, M., Oshiro, Y., Mine, M., Iwasaki, T., Yamamoto, H., Kohashi, K., Sonoda, K., Kato, K. & Oda, Y., Apr 2018, In : Histopathology. 72, 5, p. 739-748 10 p.

Research output: Contribution to journalArticle

Insulin-Like Growth Factor II
RNA-Binding Proteins
Mediator Complex
Messenger RNA
1 Citation (Scopus)

The Smallest Reported Malignant Struma Ovarii: A Case Report

Yasutake, N., Noguchi, H., Ibayashi, Y., Nakamura, H., Tateishi, K., Yuki, K., Shiina, R., Shimajiri, S. & Fujita, T., Sep 1 2018, In : Case Reports in Oncology. 11, 3, p. 693-698 6 p.

Research output: Contribution to journalArticle

Struma Ovarii
17 Citations (Scopus)
In Situ Hybridization
Papillomavirus Infections
6 Citations (Scopus)

Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma

Aman, M., Ohishi, Y., Imamura, H., Shinozaki, T., Yasutake, N., Kato, K. & Oda, Y., Jun 2017, In : Human Pathology. 64, p. 156-163 8 p.

Research output: Contribution to journalArticle

PAR-2 Receptor
Oxidative Stress
Endometrioid Carcinoma